[ET Net News Agency, 12 March 2024] HANSOH PHARMA (03692) rose 5.3% to HK$14.8.
It hits an intra-day high of HK$14.82, hitting an 1-month high, and an intra-day low of
HK$13.78. The total shares traded was 1.08 million, with a value of HK$15.68m. The active
buy/sell ratio is 75:25, with net buying turnover of HK$7.69m. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$560,401, with volume weighted
average price of HK$14.454. FUTU SEC INT'L accounts for greatest net responsive selling
turnover of HK$1.71m, with volume weighted average price of HK$14.607. The stock has risen
a combined 9.6% over the past 3 consecutive trading days.
The Hang Seng Index now rose 126 points, or 0.8% to 16,714.
Basic Information
=================
---------------------------------
Nominal 14.800 % Chg +5.26%
High 14.820 Low 13.780
Shares Tr 1.08m Turnover 15.68m
10-D SMA 13.900 %H.V 48.037
20-D SMA 13.574 VWAP 14.498
50-D SMA 13.210 RSI14 64.142
---------------------------------
Status: Hitting an 1-month high, active buy/sell ratio is 75:25, with net buying turnover
of HK$7.69m, rising a combined 9.6% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 14.80 +5.26
ALI HEALTH (00241) 3.39 +1.80
TRAD CHI MED (00570) 4.32 +0.23
CSPC PHARMA (01093) 6.18 +2.83
SINOPHARM (01099) 21.90 +2.10
SINO BIOPHARM (01177) 3.11 +4.36
CHINARES PHARMA (03320) 5.32 +2.50
SCICLONE PHARMA (06600) 13.74 +3.46
JD HEALTH (06618) 30.00 +0.84
GOLDEN THROAT (06896) 3.61 -0.55
-----------------------------------------------
(ed)